ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,564.41
      1.08%
      US Tech 100
      19,255.20
      1.29%
      Dow Jones
      40,415.44
      0.32%
      Brent Oil
      81.78
      0.33%
      Bitcoin
      67,392.42
      -0.31%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Surrozen Inc (SRZN) Quote

      Surrozen Inc

      Surrozen Inc (SRZN)

      NASDAQ
      8.44
      -0.56
      (-6.22%)
      Closed July 22 4:00PM
      Delayed by 15 minutes
      8.44
      0.00
      (0.00%)
      After Hours: 4:30PM
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      8.44
      Bid
      7.77
      Ask
      10.09
      Volume
      11,658
      8.04 Day's Range 9.105
      4.50 52 Week Range 16.19
      Market Cap
      28.789M
      Previous Close
      9.00
      Open
      9.00
      Last Trade
      341
      @
      8.44
      Last Trade Time
      Financial Volume
      $ 102,061
      VWAP
      8.7546
      Average Volume (3m)
      9,385
      Shares Outstanding
      3,198,786
      Dividend Yield
      -
      PE Ratio
      -0.62
      Earnings Per Share (EPS)
      -13.46
      Revenue
      -
      Net Profit
      -43.04M

      About Surrozen Inc

      Surrozen Inc is a class of therapeutics to treat serious diseases characterized by tissue injury. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), and SZN-043 (E3/ASGR1, SWEETS). Surrozen Inc is a class of therapeutics to treat serious diseases characterized by tissue injury. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), and SZN-043 (E3/ASGR1, SWEETS).

      Sector
      Biological Pds,ex Diagnstics
      Industry
      Biological Pds,ex Diagnstics
      Website
      www.surrozen.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      1970
      Surrozen Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker SRZN. The last closing price for Surrozen was $9. Over the last year, Surrozen shares have traded in a share price range of $ 4.50 to $ 16.19.

      Surrozen currently has 3,198,786 shares outstanding. The market capitalization of Surrozen is $28.79 million. Surrozen has a price to earnings ratio (PE ratio) of -0.62.

      SRZN Latest News

      More News

      Surrozen Publishes Study in ‘eLife’ Demonstrating the Promise of The Proprietary SWEETS Platform, a Unique Targeted Protein Degradation Technology, to Further Enhance Wnt Signaling

      Targeted protein degradation (TPD*) technologies have demonstrated the potential to produce novel treatment approaches Surrozen’s current SWEETS bispecific antibodies are unique TPD technologies...

      June 12 2024
      GlobeNewswire Inc.

      Surrozen Presents Preliminary Results from Phase 1a Study of SZN-043 in Healthy Volunteers and Patients with a History of Liver Cirrhosis at the 2024 European Association for the Study of the Liver (EASL) in Milan

      SZN-043 is a novel biotherapeutic shown to potentiate Wnt signaling and induce proliferation of hepatocytes in preclinical models Treatment with SZN-043 in the Phase 1a trial was safe and well...

      June 10 2024
      GlobeNewswire Inc.

      Surrozen Initiates Dosing of First Patient in Phase 1b Clinical Trial of SZN-043 for Severe Alcohol-Associated Hepatitis

      SZN-043 is a novel hepatocyte-specific R-spondin mimetic bispecific fusion protein targeting ASGR1Anticipate potential proof-of-concept data available in the first half of 2025 SOUTH SAN...

      June 04 2024
      GlobeNewswire Inc.

      Surrozen Presents Data Demonstrating the Promise of Antibody-Based Wnt Mimetics in Treating Cornea Endothelial Dystrophies and Dry Eye Disease at the Associations for Research in Vision and Ophthalmology (ARVO) Annual Meeting

      In preclinical models of cornea endothelial dystrophies, a Surrozen antibody-based Wnt mimetic reduced corneal edema and stimulated endothelial cell proliferation in the corneaSurrozen’s antibody...

      May 09 2024
      GlobeNewswire Inc.

      Surrozen Provides First Quarter 2024 Financial Results and Business Update

      SZN-043 Phase 1a clinical trial results to be presented at the 2024 European Association for the Study of the Liver (EASL) in Milan Preclinical data from ARVO 2024 demonstrate the promise of a...

      May 08 2024
      GlobeNewswire Inc.

      Surrozen Publishes Study in 'Respiratory Research' Demonstrating the Promise of a Wnt Mimetic Antibody in Treating Pulmonary Fibrosis

      In a preclinical model of pulmonary fibrosis, a Surrozen antibody-based SWAP platform molecule decreased pulmonary inflammation and fibrosis and improved lung function Surrozen Wnt mimetic SWAP...

      April 03 2024
      GlobeNewswire Inc.

      Surrozen Announces Safety, Pharmacodynamic and Liver Function Data for SZN-043

      -Phase 1a trial demonstrated acceptable safety and tolerability with no reported serious adverse events-Phase 1a data demonstrated target engagement, a pharmacodynamic effect and effects on liver...

      April 01 2024
      GlobeNewswire Inc.

      Surrozen Announces up to $192.5 Million Private Placement of Securities Priced At-the-Market Under Nasdaq Rules

      -   $17.5 million upfront proceeds with up to an additional $175 million of proceeds upon the exercise of warrants-   Initial capital funds expansion of Phase 1b trial in severe alcohol-associated...

      April 01 2024
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.91-9.732620320869.359.98998.0441789.29558117CS
      4-1.3-13.34702258739.74118.0469989.67151507CS
      12-0.54-6.013363028958.9811.998.04938510.23089659CS
      260.141.686746987958.316.197.151320610.72967037CS
      52-4.5065-34.808635538612.946516.194.5574188.35543557CS
      156-134.81-94.1082024433143.252104.516829531.06288432CS
      260-134.81-94.1082024433143.252104.516829531.06288432CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      MIRAMIRA Pharmaceuticals Inc
      $ 5.01
      (627.35%)
      		151.42M
      CMAXCareMax Inc
      $ 5.7101
      (261.40%)
      		100.56M
      NUKKNukkleus Inc
      $ 0.5415
      (69.22%)
      		24.87M
      SNOASonoma Pharmaceuticals Inc
      $ 0.423
      (37.34%)
      		4.57M
      LPSNLivePerson Inc
      $ 1.2999
      (31.30%)
      		8.57M
      LGCBLinkage Global Inc
      $ 3.6601
      (-29.82%)
      		168k
      CGBSCrown LNG Holdings Ltd
      $ 0.9997
      (-29.10%)
      		3.39M
      SPECSpectaire Holdings Inc
      $ 0.3962
      (-24.53%)
      		1.87M
      GSUNGolden Sun Health Technology Group Ltd
      $ 5.13
      (-23.66%)
      		158.79k
      PSNLPersonalis Inc
      $ 2.9808
      (-22.58%)
      		3.11M
      NVDANVIDIA Corporation
      $ 123.54
      (4.76%)
      		239M
      SQQQProShares UltraPro Short QQQ
      $ 8.09
      (-4.37%)
      		183.65M
      MIRAMIRA Pharmaceuticals Inc
      $ 5.01
      (627.35%)
      		158.14M
      SERVServe Robotics Inc
      $ 8.73
      (15.63%)
      		151.56M
      NCPLNetcapital Inc
      $ 0.1118
      (7.50%)
      		124.37M

      SRZN Discussion

      View Posts
      Monksdream Monksdream 4 months ago
      SRZN over $10
      👍️0
      csud1 csud1 1 year ago
      What's up with all the 100 share buys?
      👍️0
      Joelzee Joelzee 1 year ago
      Great day
      👍️0
      BEIJING BILL BEIJING BILL 2 years ago
      Buying .60s
      👍️0
      81vette 81vette 2 years ago
      sexy dilution lol>https://twitter.com/ThePberg/status/1602077645516472320/photo/1
      👍️0
      81vette 81vette 2 years ago
      where?,post link,dilution lol,gapping/running 50% is dilution how?
      👍️0
      81vette 81vette 2 years ago
      no shares to short=100s% win possible>0 2022-12-15 11:30:03,8.39% 0.00% 0 2022-12-15 11:15:03
      8.39% 0.00% 0 2022-12-15 11:00:03
      8.39% 0.00% 0 2022-12-15 10:45:03
      8.39% 0.00% 0 2022-12-15 10:30:03
      8.39% 0.00% 0 2022-12-15 10:15:04
      8.39% 0.00% 0 2022-12-15 10:00:03
      8.39% 0.00% 0 2022-12-15 09:45:04
      8.39% 0.00% 0 2022-12-15 09:30:03
      8.39% 0.00% 0 2022-12-15 09:15:04
      8.39% 0.00% 0 2022-12-15 09:00:04
      8.39% 0.00% 0 2022-12-15 08:45:03
      8.39% 0.00% 0 2022-12-15 08:30:03
      8.39% 0.00% 0 2022-12-15 08:15:03
      8.39% 0.00% 0 2022-12-15 08:00:04
      8.39% 0.00% 0 2022-12-14 17:45:04
      8.39% 0.00% 0 2022-12-14 17:30:03
      8.39% -4.57% 2000 2022-12-14 17:15:04
      8.39% -4.57% 6000 2022-12-14 17:00:03
      8.39% -4.57% 6000 2022-12-14 16:45:03
      8.39% -4.57% 10000 2022-12-14 16:30:04
      8.39% -4.57% 10000 2022-12-14 16:15:03
      8.39% -4.57% 10000
      👍️0
      81vette 81vette 2 years ago
      book value per share (mrq) $2.21
      👍️0
      willlbone willlbone 2 years ago
      Dilution news
      👍️0
      81vette 81vette 2 years ago
      no shares to short!!>Zero Borrow,Shares Outstanding 34.97M,Shares Float,32.70 institutional Ownership 70.10%,Insider Ownership 6.88%
      👍️0
      81vette 81vette 2 years ago
      loaded .46 ,bounce babe,bounce!!!
      👍️0
      willlbone willlbone 2 years ago
      Big volume today.
      👍️0
      l3gionFX l3gionFX 2 years ago
      So, I guess I'll try making a post and seeing what comes of it.

      Looks like the stock price is absolutely tanking on the bad news of pausing the clinical trials while invesitgating the liver stuff. I'm curious to know who's selling and buying right now. Obviously, it'll be too late to do anything, but I'm curious to see if there will be any of those insider trade filings or if any of the big investment funds adjusted their position.
      👍️0

      Your Recent History

      NASDAQ
      SRZN
      Surrozen
      Delayed Upgrade Clock